Recently, it has been demonstrated in the Genetic Frontotemporal Dementia Initiative (GENFI) study that gray matter and cognitive changes can be identified 5–10 years before the expected onset of symptoms in adults at risk of genetic FTD, including a cohort carrying GRN mutations (Rohrer et al., 2015). This evidence concerns the gene GRN and dementia.